DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPAN-Reference-Cited by-同舟云学术

DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPAN

Published:1984-01 Issue:8369 Volume:323 Page:122-126
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sato Y.,Kimura M.,Fukumi H.

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Japan's experience in pertussis epidemiology and vaccination in the past thirty years;Kanai;Japan J Med Sci Biol,1980

2. Leukocytosis-promoting factor of Bordetella pertussis. III. Its identity with protective antigens;Sato;Infect Immun,1974

3. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis;Sato;Infect Immun,1981

4. Attempts at analysis of toxicity of pertussis vaccine. III. Effects of endotoxin on leukocytosis in mice due to lymphocytosis-promoting factor and reference preparations for determination of lymphocytosis-promoting factor;Kurokawa;Japan J Med Sci Biol,1978

5. Body temperature reduction of pertussis vaccine-sensitized mice following histamine challenge and a new sensitive assay method for HSF;Ishida;Japan J Med Sci Biol,1978

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bordetella pertussis and other Bordetella spp. infections;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice;npj Vaccines;2024-06-10

3. Use of Mucosally Administered Outer Membrane Vesicles Derived fromBordetella pertussisto Diminish Nasal Bacterial Colonization;2024-03-13

4. BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models;Infection and Immunity;2024-03-12

5. Safety assessments of recombinant DTaP vaccines developed in South Korea;Clinical and Experimental Vaccine Research;2024